Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Medisyd AS
AS
Active
Org 979445415
Vestre Rosten 79, 7075
Tiller
General medical practice activities
·
NACE 8621
Est. 1997 · 28 years old
10 employees
Monitor
Share
Norway
/
Companies
/
General medical practice activities
/
Medisyd AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (1)
BK
Bent Korssjøen
Contact Person
Contact Person
2015 – 2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (8)
KL
Kristin Lein Rendum
Board of Directors
Board of Directors
2017
AE
Anne Elise Blokkum Pedersen
Board of Directors
Board of Directors
2017
MI
Marlene Iversen Halvorsrød
Board of Directors
Board of Directors
2026
BK
Bent Korssjøen
Board of Directors
Board of Directors
2017
LH
Lars Høsøien Skanke
Board of Directors
Board of Directors
2026
VE
Vibeke Engan Berntzen
Board of Directors
Board of Directors
2024
JC
Jakob Ciljan Skjelbred
Chairman
Chairman
2017
SB
Sigurd Baldersheim
Board of Directors
Board of Directors
2024
Former (2)
IM
Ivar Morten Jørum
Board of Directors
Board of Directors
2017 – 2024
PS
Per Schrøder
Board of Directors
Board of Directors
2017 – 2026
Shareholders
As of last annual report
Kristin Lein Rendum — 12.5%
Anne Elise Blokkum Pedersen — 12.5%
Marlene Iversen Halvorsrød — 12.5%
Bent Korssjøen — 12.5%
Lars Høsøien Skanke — 12.5%
Vibeke Engan Berntzen — 12.5%
Sigurd Baldersheim — 12.5%
Jakob Ciljan Skjelbred — 12.5%
100%
Shareholder
Type
Ownership
Votes
Since
Kristin Lein Rendum
Individual
12.5%
12.5%
2025
Anne Elise Blokkum Pedersen
Individual
12.5%
12.5%
2025
Marlene Iversen Halvorsrød
Individual
12.5%
12.5%
2025
Bent Korssjøen
Individual
12.5%
12.5%
2025
Lars Høsøien Skanke
Individual
12.5%
12.5%
2025
Vibeke Engan Berntzen
Individual
12.5%
12.5%
2025
Sigurd Baldersheim
Individual
12.5%
12.5%
2025
Jakob Ciljan Skjelbred
Individual
12.5%
12.5%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Medisyd AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network